Abstract OBJECTIVES: The prognosis of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries (PA-VSDMAPCAs) after surgery shows substantial clinical heterogeneity and predictors for outcomes are lacking. This study aimed to assess the predictive value of preoperative cardiac computed tomography angiography (CTA) for survival in patients with PA-VSD-MAPCAs.
INTRODUCTION
Pulmonary atresia with a ventricular septal defect and major aortopulmonary collateral arteries (PA-VSD-MAPCAs) is a relatively rare and complex congenital heart malformation that is estimated to occur in 10 of 100 000 live-born infants and has a high rate of natural attrition [1, 2] . The main treatment for PA-VSD-MAPCAs remains highly controversial because of their erratic morphologic features. The main therapeutic method includes right ventricular outflow tract reconstruction (RVOTR) and MAPCA unifocalization or pulmonary artery rehabilitation without MAPCA unifocalization. †Qianjun Jia, Jianzheng Cen and Changhong Liang contributed equally to this work.
Previous studies have reported that these methods improve the prognosis relative to the untreated natural history [3] [4] [5] [6] [7] [8] [9] . However, patients receiving the same treatment can still show substantial clinical heterogeneity [7, 9] , which highlights the need for prognosticators to predict survival for patients with PA-VSD-MAPCAs.
Numerous attempts have been made to establish useful prognostic indicators for PA-VSD-MAPCs. The McGoon ratio, pulmonary arterial index and total neopulmonary artery index (TNPAI) were reported to have prognostic value. However, data based on these pretreatment morphological characteristics are controversial [6, 10, 11] , as many studies included heterogeneous PA-VSD patients both with and without MAPCAs [11, 12] . In addition, it has been shown that the pulmonary vein index (PVI) provides a more accurate indicator of pulmonary blood flow than that of the pulmonary arteries [13, 14] . Because pulmonary blood flow is associated with the prognosis of patients with PA-VSDMAPCAs [15, 16] , PVI may be a useful morphological prognostic indicator for these patients. However, the prognostic value of PVI in patients with PA-VSD-MAPCAs has never been evaluated.
In recent years, the diagnostic methods and preoperation imaging of PA-VSD-MAPCAs have undergone tremendous changes. Multi-detector cardiac computed tomography angiography (CTA) technology with improved spatial and temporal resolution has become available in clinical practice and represents a non-invasive method that is effective even at high heart rates. In fact, the application of cardiac CTA has gradually replaced conventional angiography (CA) in the diagnosis and evaluation of congenital heart disease [17] . Therefore, it is of interest to determine the predictive significance of prognostic factors in the modern modality of CTA.
Herein, we reviewed our prospectively maintained congenital heart disease registry and sought to assess the predictive value of preoperative quantitative CTA indexes for PA-VSD-MAPCA patients, particularly with respect to the role of preoperative quantitative CTA indexes in establishing prognostic subsets of PA-VSDMAPCAs and appropriate treatment strategies.
MATERIALS AND METHODS

Study population
After obtaining institutional review board approval, we reviewed our prospectively maintained congenital heart disease database between September 2007 and September 2015. Informed consent was obtained from all patients (or their legally authorized representative). A flowchart of our study is provided in Fig. 1 . During the study period, 72 patients with PA-VSD-MAPCAs who had undergone RVOTR and MAPCA unifocalization or pulmonary artery rehabilitation without MAPCA unifocalization were screened, and 52 patients were enrolled in the study. Patients were divided into 2 groups on the basis of operative strategy: (i) the pulmonary artery rehabilitation group (underwent RVOTR with pulmonary artery rehabilitation without MAPCA unifocalization) and (ii) the unifocalization group (underwent RVOTR with MAPCA unifocalization). The relationship between MAPCAs and the native pulmonary artery (NPA) was assessed by preoperative CTA. Of particular importance to our surgical approach was determining whether a MAPCA was communicating with the NPA. If the MAPCAs were not communicating with the NPA, the patient was allocated to the unifocalization group; otherwise, the patient was allocated to the pulmonary artery rehabilitation group.
In patients who were not suitable for complete repair, the VSD was left open. If the patient had a preoperative TNPAI <200 mm 2 /m 2 and was not haemodynamically stable after weaning from cardiopulmonary bypass, cardiopulmonary bypass was reinstituted, and fenestration of the VSD patch was performed.
Computed tomography angiography protocol
Baseline CTA was performed within 4 weeks before treatment. Images were obtained using a 64-slice CT scanner or a 256-slice Multi-detector CT scanner. Details regarding the cardiac CTA protocol have been reported previously [18] .
Computed tomography angiography image and data analysis CT images were analysed on a commercial workstation. The areas were obtained from the reformatted angiographic images by manually drawing the region of interests (Fig. 2) . The true PAs were measured just before their bifurcation, as described by Nakata et al. [19] . MAPCAs sizes were measured immediately distal to the site that was most likely for surgical unifocalization and beyond any central stenosis, if present. The sizes of the pulmonary veins were measured proximal to their entrance to the left atrium and 5 mm away from the entrance. The McGoon index, TNPAI and PVI were calculated according to the sum of the bilateral pulmonary arterial diameters divided by the descending aorta diameter at the diaphragm level, the sum of the bilateral pulmonary arterial and collateral vessel cross-section areas divided by the body surface areas and the sum of the cross-sectional areas of all pulmonary veins divided by the body surface area, respectively. In addition, the absence or presence of NPA and the number of bronchopulmonary segments supplied by native pulmonary arteries (BSSNPAs) were counted (20 total pulmonary segments for each patient). The presence of NPA was defined according to the presence of PAs, either single or bilateral, regardless of pulmonary arterial confluence or main pulmonary trunk; the absence of NPA was defined as no central pulmonary artery detected or pulmonary blood supplied by MAPCAs.
To assess intra-observer variability of the McGoon index, TNPAI and PVI measurements, 1 observer performed a second reformatting and reading in a blinded fashion 1 month or longer after the initial assessment (to minimize recall bias) in a group of 30 randomly selected patients. In addition, in a random sample of 10 patients, angiographic images were formatted and measurements were performed by 2 independent observers who were blinded to the counterpart's results, and the interobserver variability was calculated. The absence or presence of NPA and the number of BSSNPAs were evaluated by 2 radiologists independently, and disagreements were resolved by means of joint interpretation.
Follow-up and statistical analysis
Patients returned for follow-up appointments at least every 6 months during the first 3 years and annually thereafter until death. The endpoint was overall survival, calculated from the first day of definitive surgery to the day of death or the last examination. The time of last follow-up was 25 September 2015, and the median follow-up period for the entire cohort was 1145 days (range: 0-3451 days). Mortality was defined as early (within 30 days) or late.
The Statistical Package for Social Sciences, version 13.0 and MedCalc 12.1.4.0 were used for all statistical analyses. Student's t-test was used for normally distributed data, whereas MannWhitney U-test was used for non-normally distributed data; the v 2 test was used for categorical variables. The accuracy of PVI in predicting the possibility of VSD closure was analysed using the area under the receiver-operator characteristics (ROC) curve. Actuarial rates were calculated using the Kaplan-Meier method, and the differences were compared using the log-rank test. Significant variables in univariate analysis (P < 0.1) were further tested in multivariate analyses using the Cox proportional hazards model. Host factors (including age and gender) and clinical factors (including operative strategy) were included as covariates in all tests. Independent significant factors were assessed using ROC curves to estimate the cut-off point. Bland-Altman analysis was used to evaluate intra-and interobserver variability [20] . A 2-tailed P-value of <0.05 was considered statistically significant.
RESULTS
Clinical characteristics and outcomes of the study cohort
The median age of the study cohort was 37 months (range: 1-288 months). Of the 52 patients, 33 (64%) were men. A flow diagram demonstrating the treatment method and outcomes is shown in Supplementary Material, Fig. S1 . In the pulmonary artery rehabilitation group (n = 24) and unifocalization group (n = 28), 63% (15 of 24) and 43% (12 of 28) of patients had VSD closure, respectively. The clinical characteristics of the study group according to the 2 different surgical managements are presented in Table 1 . No significant difference was observed between the pulmonary artery rehabilitation group and the unifocalization group in terms of mortality, age, gender, weight, body surface area, TNPAI, PVI, BSSNPA and VSD open or closure (all P-values >0.05). CT indexes of the McGoon index (P = 0.01) and the presence or absence of NPA (P < 0.01) significantly differed between the 2 groups. Table 2 demonstrates the reproducibility of the measurements of the McGoon index, TNPAI and PVI, which showed excellent reproducibility for all 3 of these CT indexes.
Univariable and multivariable analyses
In a univariate Cox regression analysis, the CT parameters of PVI, BSSNPA and the presence or absence of NPA were identified as outcome predictors (Table 3) . Using variables that were found to be significant in univariate analysis, host factors (including age and gender) and clinical factors (including operative strategy), multivariate analysis was performed. According to multivariable analysis, a high PVI [hazard ratio (HR) = 0.03; 95% confidence interval (CI): 0.03, 0.28; P < 0.01] and present NPA (HR = 0.06; 95% CI: 0.10, 0.35; P < 0.01) both exhibited independent predictive values for good survival (Table 3) .
Identification of a pulmonary vein index cut-off point
PVI could not predict successful VSD closure: area under the receiver-operator curve (0.52), P = 0.79. The cut-off point of PVI for overall survival (n = 52) was 438 mm 2 /m 2 (sensitivity 92%, specificity 72%; area under the ROC = 0.79, P < 0.01) (as shown in Fig. 3 
Survival analysis
There were a total of 13 deaths. Of the 13 deaths, 6 events (46%) occurred within 30 days. The mean time between the first procedure performed and mortality was 2454 ± 230 days (95% CI: 2003.77, 2903.58). The Kaplan-Meier survival curves for all treated patients showed that the 5-year overall survival rate was 78% (Supplementary Material, Fig. S2 ). Six events (25% for mortality rate) occurred in the pulmonary artery rehabilitation group, and 7 events (25% for mortality rate) occurred in the unifocalization group. No significant difference was observed between the MAPCA unifocalization group and the pulmonary artery rehabilitation group (log-rank test, P = 0.38; Fig. 4A ). Patients with a high PVI showed significantly better overall outcomes than those with a low PVI for the whole cohort (log-rank test, P < 0.01; Fig. 4B ). Patients with NPA showed significantly better outcomes than those without NPA (log-rank test, P = 0.01). Additionally, PVI and NPA presence allowed clear discrimination between patients with and without mortality (log-rank test, P < 0.01), exhibiting an independent and additive value. Thus, patients with a high PVI and NPA presence (n = 24) showed the highest survival rates (100%), followed by those with a high PVI and the absence of NPA (n = 5, 80% for survival rates) and those with a low PVI and the presence of NPA (n = 20, 55% for survival rates). In contrast, those with a low PVI and the absence of NPA exhibited worse outcomes (n = 3, 0% for survival rates).
DISCUSSION
The prognostic value of preoperation CTA indexes remains unknown in patients with PA-VSD-MAPCAs. Our major finding is that PVI and NPA presence were 2 significant positive factors for PA-VSD-MAPCA patients who underwent both RVOTR and MAPCA unifocalization or pulmonary artery rehabilitation; this finding may provide a reliable non-invasive way to establish prognostic subsets for PA-VSD-MAPCAs before treatment.
Management and survival of PA-VSD-MAPCA patients
To date, the surgical management of PA-VSD-MAPCAs has been somewhat controversial. Many studies have suggested the unifocalization of collateral arteries to create a new pulmonary vascular bed, and results have shown this strategy to result in improved survival compared to patients with an untreated natural history [9, 15, 16, 21] . Other authors continue to advocate the use of the right ventricle to pulmonary artery conduit as the principal method to achieve pulmonary artery rehabilitation without unifocalization [8, 22] . Unfortunately, limited data regarding the direct comparison of these 2 management types have been published. Our data demonstrated that the survival rates were similar in PA-VSD-MAPCA patients regardless of MAPCA unifocalization or pulmonary artery rehabilitation. According to our study, the 5-year overall survival rate for the whole cohort was 78%. These results were somewhat inconsistent with the study by Kaskinen et al. [11] who reported a 5-year survival rate of 66%, but consistent with the study by Amark et al. [12] who reported a 5-year survival rate of 74%. Two possible explanations may account for these discrepancies. First, the enrolled patients in the study by Kaskinen et al. [11] included PA-VSD patients both with and without MAPCAs. In comparison, our study only focused on PA-VSD patients with MAPCAs. Moreover, the operation strategies adopted in the previous study were highly heterogeneous, while our study only included patients treated with both RVOTR and MAPCA unifocalization or The mean difference is expressed as the percentage of the average of 2 measurements. SD: standard deviation; TNPAI: total neopulmonary artery index; PVI: pulmonary vein index. Clinically or statistically significant variables in the univariate analysis (P < _ 0.1) were included in the multivariate analysis. PVI: pulmonary vein index; TNPAI: total neopulmonary artery index; NPA: native pulmonary artery; BSSNPA: bronchopulmonary segments supplied by native pulmonary arteries; VSD: ventricular septal defect; CI: confidence interval.
a Variables that were not significant in the univariate analysis were not included in the multivariate analysis.
pulmonary artery rehabilitation without MAPCA unifocalization, which represent 2 commonly used treatment strategies for this type of disease.
Prognostic significance of pulmonary vein index and native pulmonary artery
Generally, pulmonary blood flow reflects the functionality of the entire pulmonary vasculature, which significantly affects the prognosis of patients with PA-VSD-MAPCAs [15, 16] . Parameters associated with the size of PAs and pulmonary veins have been the 2 most commonly used parameters to represent pulmonary blood flow [13, 19, 23] . In the present cohort, TNPAI and the McGoon index, which reflect the size of the pulmonary arteries, were found to be of no significance on the prognostic value of PA-VSD-MAPCAs. In contrast, we identified the presence of NPA to be an independent prognostic factor; this result was consistent with Ishibashi et al. [10] who reported the relationship between the hypoplastic central pulmonary artery and negative survival in patients with PA-VSD-MAPCAs using conventional angiography. Another independent predictor of survival for PA-VSD-MAPCA patients identified in our study was PVI, which may provide important information about differences in blood flow and vascular resistance between each lung in patients with congenital heart disease [13] . These findings were of interest, as the diameter of PAs instead of veins is commonly used as an indicator of a pulmonary vascular bed and pulmonary blood flow. Our results were similar to those of Kawahira et al. [13] who suggested that the pulmonary vein area may be more useful than the PAs to indicate pulmonary blood flow. Furthermore, PVI appears to be a more useful morphological indicator of pulmonary blood flow and may improve the decision-making strategy for patients presenting with a univentricular heart.
Advantages of computed tomography angiography over conventional angiography
Most previously reported morphological indexes were obtained using conventional angiography. As a result of rapid advances in multi-detector CTA technology with improved spatial and temporal resolution, cardiac CT examinations at high heart rates are feasible, making paediatric cardiac CTA in congenital heart disease possible [24] [25] [26] . Given that the margin of the PVs becomes vague in conventional angiography because it is overlapped by the image of the ventricle, we aimed to comprehensively investigate these parameters utilizing cardiac CTA, which is a more accurate and convenient imaging modality in the preoperation evaluation of congenital heart diseases. Utilizing cardiac CTA, Jung et al. [27] calculated the changes in PVI to assess the effect of sutureless repair for pulmonary vein anomalies. Cardiac CTA is accurate in the preoperative evaluation of infants with MAPCAs [28] and showed potential to replace conventional angiography for evaluating pulmonary artery atresia non-invasively in PA-VSD patients [17] . To the best of our knowledge, no preoperative quantitative CTA indexes have been reported to predict the results after surgical treatment in patients with PA-VSD-MAPCAs. Our study showed that a high PVI measured using reoperation CTA is a strong and an independent predictor of outcomes in patients with PA-VSD-MAPCAs. The PVI cut-off points were calculated by ROC analysis with a high sensitivity and specificity, which could be conveniently applied to categorize the hazard level of disease within risk hierarchies that predict outcome. Because PA-VSD-MAPCAs carry a high rate of natural attrition, the identification and stratification of patients at high risk could optimize treatment strategies.
Limitations
Given the inherent limitations of a retrospective study, the current results need to be confirmed in prospective studies with a larger sample size. However, because PA-VSD-MAPCA is a relatively rare disease, the difficulty of conducting large prospective studies enables our findings to be of clinical utility in establishing prognostic subsets and appropriate treatment strategies for this disease. In addition, the current study only focused on PA-VSD-MAPCA patients receiving both RVOTR and MAPCA unifocalization or pulmonary artery rehabilitation to ensure the homogeneity of the patient population, and the operation method was mainly operator dependent. Because there was no consensus in the surgical indications and criteria of this disease, the results of this study may be not applicable to patients under other surgical procedures. Finally, our research only focused on survival status postoperation, while other outcome measures, such as the development of pulmonary arteries, clinical status and oxygen saturation, were not included in the present study. In fact, these outcome measures may preferably reflect the improvement of cardiac function in patients after intervening measures and may represent reliable survival indicators; our future work will research these aspects.
CONCLUSIONS
In conclusion, our study demonstrates that a high PVI and NPA presence confirmed via cardiac CTA are significant predictors of a positive survival advantage in PA-VSD-MAPCAs patients, with definite advantages regardless of the operation method. These findings may aid in improving the decision-making strategy for PA-VSD-MAPCA patients.
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